Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

Clinical trial NCT03929094 · UNKNOWN

Trial details

NCT number: NCT03929094
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2019-03-01
Primary completion: 2021-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.